SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer

Inhibition of SWI/SNF-mediated chromatin remodeling represses multiple cancer hallmarks in triple-negative breast cancer by blocking chromatin access for diverse transcription factors at shared enhancers, demonstrating the therapeutic potential of targeting DNA access.